Related references
Note: Only part of the references are listed.Pyk2 and FAK differentially regulate invadopodia formation and function in breast cancer cells
Alessandro Genna et al.
JOURNAL OF CELL BIOLOGY (2018)
CCL18-dependent translocation of AMAP1 is critical for epithelial to mesenchymal transition in breast cancer
Haiyan Li et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
The human ion channel TRPM2 modulates neuroblastoma cell survival and mitochondrial function through Pyk2, CREB, and MCU activation
Iwona Hirschler-Laszkiewicz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2018)
Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4-NDRG1 Axis
Nandini Verma et al.
CANCER RESEARCH (2017)
Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production
Xinfang Yu et al.
MOLECULAR CARCINOGENESIS (2017)
E-cadherin expression is correlated with focal adhesion kinase inhibitor resistance in Merlin-negative malignant mesothelioma cells
T. Kato et al.
ONCOGENE (2017)
Chemotherapy-Induced Ca2+ Release Stimulates Breast Cancer Stem Cell Enrichment
Haiquan Lu et al.
CELL REPORTS (2017)
Focal adhesion kinase signaling in unexpected places
Elizabeth G. Kleinschmidt et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer
Evangelos Koustas et al.
CANCER LETTERS (2017)
Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma
M. B. Meads et al.
ONCOGENE (2016)
PYK2 via S6K1 regulates the function of androgen receptors and the growth of prostate cancer cells
Yu-Hsuan Hsiao et al.
ENDOCRINE-RELATED CANCER (2016)
Activation of focal adhesion kinase through an interaction with β4 integrin contributes to tumorigenicity of colon cancer
Yu-Ling Tai et al.
FEBS LETTERS (2016)
Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer
Go Omura et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Epidermal growth factor receptor expression in carcinoma gallbladder: A prospective study in Indian scenario
Nidhish Kumar et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling
Denis Lane et al.
MOLECULAR CANCER (2016)
Oncogenic Receptor Tyrosine Kinases Directly Phosphorylate Focal Adhesion Kinase (FAK) as a Resistance Mechanism to FAK-Kinase Inhibitors
Timothy A. Marlowe et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Understanding the CREB1-miRNA feedback loop in human malignancies
Ya-Wen Wang et al.
TUMOR BIOLOGY (2016)
The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma
Yusuke Kamihara et al.
ONCOTARGET (2016)
Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells
Heike Wiese et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
A. Harle et al.
BRITISH JOURNAL OF CANCER (2015)
Down-regulation of ALDH1A3, CD44 or MDR1 sensitizes resistant cancer cells to FAK autophosphorylation inhibitor Y15
Vita Golubovskaya et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
The role of Pyk2 in the CCR7-mediated regulation of metastasis and viability in squamous cell carcinoma of the head and neck cells in vivo and in vitro
Yang Yue et al.
ONCOLOGY REPORTS (2015)
Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer
Mingqun Li et al.
ONCOLOGY LETTERS (2015)
PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition
Nandini Verma et al.
NATURE COMMUNICATIONS (2015)
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer
Sandra Misale et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
CCR7 Regulates Cell Migration and Invasion through JAK2/STAT3 in Metastatic Squamous Cell Carcinoma of the Head and Neck
Fa-Yu Liu et al.
BIOMED RESEARCH INTERNATIONAL (2014)
High Expression of Proline-Rich Tyrosine Kinase2 is Associated with Poor Survival of Hepatocellular Carcinoma via Regulating Phosphatidylinositol 3-Kinase/AKT Pathway
Jie Cao et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival
B-H Kuang et al.
BRITISH JOURNAL OF CANCER (2013)
Overexpression of focal adhesion kinase correlates with increased lymph node metastasis and poor prognosis in non-small-cell lung cancer
Hong-Fei Ji et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Pharmacokinetics/pharmacodynamics (PK/PD) of GSK2256098, a Focal Adhesion Kinase (FAK) Inhibitor, in Patients with Advanced Solid Tumors
H. Gan et al.
EUROPEAN JOURNAL OF CANCER (2012)
Safety, Pharmacokinetic, and Pharmacodynamic Phase I Dose-Escalation Trial of PF-00562271, an Inhibitor of Focal Adhesion Kinase, in Advanced Solid Tumors
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Proline-Rich Tyrosine Kinase 2 (Pyk2) Regulates IGF-I-Induced Cell Motility and Invasion of Urothelial Carcinoma Cells
Marco Genua et al.
PLOS ONE (2012)
Clinical significance of high focal adhesion kinase gene copy number and overexpression in invasive breast cancer
Cha Kyong Yom et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab
Toni M. Brand et al.
CANCER BIOLOGY & THERAPY (2011)
How focal adhesion kinase achieves regulation by linking ligand binding, localization and action
Stefan T. Arold
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Compensatory Function of Pyk2 Protein in the Promotion of Focal Adhesion Kinase (FAK)-null Mammary Cancer Stem Cell Tumorigenicity and Metastatic Activity
Huaping Fan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition
Chris K. Sun et al.
PLOS ONE (2011)
The Role of Proline Rich Tyrosine Kinase 2 (Pyk2) on Cisplatin Resistance in Hepatocellular Carcinoma
Wei Geng et al.
PLOS ONE (2011)
Targeting Pyk2 for therapeutic intervention
Christopher A. Lipinski et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Michael D. Schaller
JOURNAL OF CELL SCIENCE (2010)
TROY (TNFRSF19) Is Overexpressed in Advanced Glial Tumors and Promotes Glioblastoma Cell Invasion via Pyk2-Rac1 Signaling
Vincent M. Paulino et al.
MOLECULAR CANCER RESEARCH (2010)
Proline-rich tyrosine kinase-2 is critical for CD8 T-cell short-lived effector fate
Soeren Beinke et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells
John G. Allen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Sunitinib and PF-562,271 (FAK/Pyk2 inhibitor) effectively block growth and recovery of human hepatocellular carcinoma in a rat xenograft model
Cedo M. Bagi et al.
CANCER BIOLOGY & THERAPY (2009)
Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism
Maria Grazia Cattaneo et al.
EXPERIMENTAL CELL RESEARCH (2009)
Structural Characterization of Proline-rich Tyrosine Kinase 2 (PYK2) Reveals a Unique (DFG-out) Conformation and Enables Inhibitor Design
Seungil Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The Pyk2 FERM domain as a target to inhibit glioma migration
Joseph C. Loftus et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Implications for KRAS status and EGFR-targeted therapies in metastatic CRC
Nicola Normanno et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Focal Adhesion Kinase-Related Proline-Rich Tyrosine Kinase 2 and Focal Adhesion Kinase Are Co-Overexpressed in Early-Stage and Invasive ErbB-2-Positive Breast Cancer and Cooperate for Breast Cancer Cell Tumorigenesis and Invasiveness
Emy Behmoaram et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors - Implications for bone metastases
Cedo M. Bagi et al.
CANCER (2008)
RhoC promotes metastasis via activation of the Pyk2 pathway, in prostate cancer
Megumi Iiizumi et al.
CANCER RESEARCH (2008)
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation
Chris K. Sun et al.
CARCINOGENESIS (2008)
Signal integration: a framework for understanding the efficacy of therapeutics targeting the human EGFR family
H. Michael Shepard et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
SKI-606 (bosutinib), a novel Src kinase inhibitor, suppresses migration and invasion of human breast cancer cells
Adina Vultur et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer
Siyang Zhang et al.
LUNG CANCER (2008)
Drug therapy: EGFR antagonists in cancer treatment
Fortunato Ciardiello et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Essential role of Pyk2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells
S. Roelle et al.
ONCOGENE (2008)
ErbB-2 via PYK2 upregulates the adhesive ability of androgen receptor-positive human prostate cancer cells
T-C Yuan et al.
ONCOGENE (2007)
The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence
C. K. Sun et al.
BRITISH JOURNAL OF CANCER (2007)
Up-regulation of focal adhesion kinase in non-small cell lung cancer
Stephana Carelli et al.
LUNG CANCER (2006)
Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: Novel heregulin/HER3-stimulated signaling pathway in glioma
EH van der Horst et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Key role of proline-rich tyrosine kinase 2 in interleukin-8 (CXCL8/IL-8)-mediated human neutrophil chemotaxis
V Di Cioccio et al.
IMMUNOLOGY (2004)
Biological significance of focal adhesion kinase in ovarian cancer - Role in migration and invasion
AK Sood et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration
M Okigaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Structural basis of adhesion-molecule recognition by ERM proteins revealed by the crystal structure of the radixin-ICAM-2 complex
K Hamada et al.
EMBO JOURNAL (2003)
Proline-rich tyrosine kinase 2 regulates proliferation and differentiation of prostate cells
A Picascia et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion
S Zrihan-Licht et al.
ONCOGENE (2000)
Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain
MA Pearson et al.
CELL (2000)
Structural basis of the membrane-targeting and unmasking mechanisms of the radixin FERM domain
K Hamada et al.
EMBO JOURNAL (2000)
Pyk2 and FAK regulate neurite outgrowth induced by growth factors and integrins
I Ivankovic-Dikic et al.
NATURE CELL BIOLOGY (2000)
Share Paper
